Surrounded by family, friends, colleagues, mentors and others, six remarkable women were celebrated on Thursday, March 7th for their unwavering dedication in their respective fields....
There are long-standing health disparities for communities of color and LGBTQIA+ in Wisconsin and Illinois. Many causes exist for these disparities, such as inadequate access to health care, environmental factors, lack of financial resources, historically inequitable approaches to treatment, and racism....
The US Food and Drug Administration (FDA) is outlining a standardized approach for collecting and reporting on race and ethnicity data in clinical trials and studies in a new draft guidance document....
As new treatments reach the market, a problem appears: real-world research shows dissatisfying outcomes and access disparities. One US study reveals that within the early years of a novel interventional device usage, women fare significantly worse than men, even after accounting for underlying differences....
A growing study in Wisconsin is focused on understanding Alzheimer’s disease and its impact on the African American community. ...
Lauren W. Yowelunh McLester-Davis, a University of Wisconsin–Madison neuroscientist and researcher, has joined the Native American Center for Health Professions (NACHP) in the UW School of Medicine and Public Health as its first director of Indigenous science advocacy....
The Association of Clinical Research Professionals (ACRP) is proud to announce the launch of the Access for Students to Clinical Research Training (ASCRT) Scholarship program. ASCRT will award scholarships of $5,000 each to five students from underrepresented groups who are enrolled in a community college,...
In recognition of National Hispanic Heritage Month The Association of Clinical Resrarch Professionals (ACRP) reached out to some cultural communications professionals to discuss the importance of clear communications between study teams and participants in clinical trials, no matter what their native languages may be....
Experts say a wider diverse pool of patients needs to be given a chance to participate in clinical research to get rare disease drugs faster to market....
Sponsors can employ several postmarketing strategies to beef up safety and efficacy data on populations that were under-represented in initial clinical trials of drugs and biologics, according to new draft guidance issued by the US Food and Drug Administration (FDA)....
